©The Author(s) 2025.
World J Gastroenterol. Oct 28, 2025; 31(40): 111727
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111727
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111727
Table 4 Individual stratification according to risk class categories of hepatocellular carcinoma and GALAD, n (%)
| GALAD categories | Very low risk (0%-10%) | Low risk (10%-25%) | Moderate risk (25%-50%) | High risk (50%-75%) | Very high risk (75%-100%) |
| HCC vs healthy | |||||
| ≤ -1.6699655 | 953 (100.00) | 88 (51.16) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
| > -1.6699655 | 0 (0.00) | 84 (48.84) | 99 (100.00) | 59 (100.00) | 148 (100.00) |
| Cirrhosis vs HCC | |||||
| ≤ -0.77471435 | 953 (100.00) | 172 (100.00) | 41 (100.00) | 0 (0.00) | 0 (0.00) |
| > -0.77471435 | 0 (0.00) | 0 (0.00) | 0 (0.00) | 15 (100.00) | 148 (100.00) |
- Citation: Villa E, Donghia R, Coletta S, Bonfiglio C, Critelli RM, Ancona A, Shahini E, Iacovazzi PA, Cozzolongo R, Pavone F, Carella N, Pontisso P, Martini A, Al Aoua S, Bantel H, Giannelli G. Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma. World J Gastroenterol 2025; 31(40): 111727
- URL: https://www.wjgnet.com/1007-9327/full/v31/i40/111727.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i40.111727